Verschraegen, C. F., Vincent, M., Abbruzzese, J. L., Siegler, D., Kavanagh, J. J., Loyer, E., … Rubin, E. (2000). Phase I study of 9-nitro-20(S)-camptothecin in combination with cisplatin for patients with advanced malignancies. In Ann N Y Acad Sci (Vol. 922, pp. 345–348). United States. https://doi.org/10.1111/j.1749-6632.2000.tb07061.x

Verschraegen, C. F., M. Vincent, J. L. Abbruzzese, D. Siegler, J. J. Kavanagh, E. Loyer, A. P. Kudelka, and E. Rubin. “Phase I study of 9-nitro-20(S)-camptothecin in combination with cisplatin for patients with advanced malignancies.” In Ann N Y Acad Sci, 922:345–48, 2000. https://doi.org/10.1111/j.1749-6632.2000.tb07061.x.

Verschraegen CF, Vincent M, Abbruzzese JL, Siegler D, Kavanagh JJ, Loyer E, et al. Phase I study of 9-nitro-20(S)-camptothecin in combination with cisplatin for patients with advanced malignancies. In: Ann N Y Acad Sci. 2000. p. 345–8.

Verschraegen, C. F., et al. “Phase I study of 9-nitro-20(S)-camptothecin in combination with cisplatin for patients with advanced malignancies.” Ann N Y Acad Sci, vol. 922, 2000, pp. 345–48. Pubmed, doi:10.1111/j.1749-6632.2000.tb07061.x.

Verschraegen CF, Vincent M, Abbruzzese JL, Siegler D, Kavanagh JJ, Loyer E, Kudelka AP, Rubin E. Phase I study of 9-nitro-20(S)-camptothecin in combination with cisplatin for patients with advanced malignancies. Ann N Y Acad Sci. 2000. p. 345–348.